Oncolys Biopharma Inc (4588) Stock Price & News

Why is 4588 down 5.42%?

Dive Deeper

4588:TYO

Oncolys Biopharma Inc

¥6,460.00

-5.42%

(-370.00) 1D

Oct 7, 11:22:34 AM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4588...

Open

¥6,750

High

¥6,790

Low

¥6,290

Mkt. cap

190.64B

Avg. vol.

1.93M

Volume

1.15M

52-wk high

¥6,850

52-wk low

¥668

EPS

-¥54

Shares outstanding

13.14M

No. of employees

Open

¥6,750

High

¥6,790

Low

¥6,290

Mkt. cap

190.64B

Avg. vol.

1.93M

Volume

1.15M

52-wk high

¥6,850

52-wk low

¥668

EPS

-¥54

Shares outstanding

13.14M

No. of employees

Related stocks

4594

BrightPath Biotherapeutics Co Ltd

¥45.00

-2.17%

4596

Kubota Pharmaceutical Holdings Co Ltd

News stories

From web sources and news partners

VT Markets

43 minutes ago

S&P 500 futures test 7,800 as AI rally persists amid bearish retail sentiment and macro headwinds

BigGo Finance

1 hour ago

S&P 500 and Nasdaq Close at Record Highs; Google Nuclear Power Deal Ignites Utilities Sector

富途牛牛

1 hour ago

10-year U.S. Treasury yields surge to 5.3%, while the Nasdaq and S&P 500 hit new highs—how should we interpret this unusual equity-bond dynamic?

RFI

5 hours ago

US stocks hit fresh records as oil stabilizes on rising supplies

About Oncolys Biopharma Inc

CEO-

Employees45

FoundedMar 18, 2004

Headquarters-

SectorBiotechnology

Websiteoncolys.com

All values in JPY	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Revenue	28.55M	-	3.09M	500.00M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	510.47M	303.94M	423.81M	846.89M
Operating expense	511.47M	305.01M	423.81M	849.46M
Total operating expenses	511.47M	305.01M	423.81M	849.46M
Operating income	-482.92M	-305.01M	-420.72M	-349.46M
Other non operating income	13.00K	-8.69M	-2.14M	-62.00K
EBT including unusual items	-500.86M	-302.92M	-413.36M	-347.24M
EBT excluding unusual items	-500.86M	-302.92M	-413.36M	-347.24M
Income tax expense	713.00K	891.00K	1.12M	430.00K
Effective tax rate	-0.14%	-0.29%	-0.27%	-0.12%
Other operating expenses	-	-	-	-
Net income	-501.58M	-303.81M	-414.48M	-347.67M
Net profit margin	-1,757.08%	-	-13,413.66%	-69.53%
Earnings per share	-	-	-	-
Interest and investment income	479.00K	1.52M	3.04M	199.00K
Interest expense	-1.20M	-1.51M	-2.99M	-5.85M
Net interest expenses	-725.00K	10.00K	58.00K	-5.65M
Depreciation and amortization charges	-	-	-	-
EBITDA	-482.90M	-304.80M	-420.71M	-349.42M
Gain or loss from assets sale	-	-	-	-

Ask anything